Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival

Abstract Background NETTER-1 trial demonstrated high efficacy and low toxicity of four cycles of Peptide Receptor Radionuclide Therapy (PRRT) in patients with metastasized NET. The present study evaluates the outcome of further PRRT cycles in the so called salvage setting in patients after initial r...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: S. Rudisile, A. Gosewisch, V. Wenter, M. Unterrainer, G. Böning, F. J. Gildehaus, W. P. Fendler, C. J. Auernhammer, C. Spitzweg, P. Bartenstein, A. Todica, H. Ilhan
格式: Artigo
語言:Inglês
出版: BMC 2019-08-01
叢編:BMC Cancer
主題:
PRRT
Salvage therapy
NET
SPECT
Dosimetry
Survival
在線閱讀:http://link.springer.com/article/10.1186/s12885-019-6000-y
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍